Caitlin Colling
Overview
Explore the profile of Caitlin Colling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simic P, Dudzinski D, Masuodi B, Colling C, Liu L
N Engl J Med
. 2025 Mar;
392(11):1121-1132.
PMID: 40073314
No abstract available.
2.
Haff N, Horn D, Bhatkhande G, Sung M, Colling C, Wood W, et al.
Am Heart J
. 2025 Feb;
285:39-51.
PMID: 39986337
Background: Sodium-glucose cotransporter-2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP-1RA) medications reduce the risk of cardiovascular and renal complications among patients with type 2 diabetes but are underutilized. There...
3.
Blood A, Chang L, Colling C, Stern G, Gabovitch D, Zelle D, et al.
Am Heart J
. 2025 Jan;
282:114-124.
PMID: 39778759
Background: The prevalence, chronicity and clinical impact of type 2 diabetes (T2D) defines this disease state as a critical determinant in morbidity and mortality, as encountered by individuals, health care...
4.
Hassan S, Chang L, Gabovitch D, Chasse J, Stern G, Colling C, et al.
Am Heart J
. 2024 Sep;
278:181-185.
PMID: 39303834
We describe the strategies used to identify and enroll participants in a remote health management program aimed at optimizing diabetes care in patients at high cardiovascular and kidney risk. Using...
5.
Blood A, Chang L, Hassan S, Chasse J, Stern G, Gabovitch D, et al.
Circulation
. 2024 Apr;
149(23):1802-1811.
PMID: 38583146
Background: Several SGLT2i (sodium-glucose transport protein 2 inhibitors) and GLP1-RA (glucagon-like peptide-1 receptor agonists) reduce cardiovascular events and improve kidney outcomes in patients with type 2 diabetes; however, utilization remains...
6.
Colling C, Rosen C
NEJM Evid
. 2024 Feb;
1(4):EVIDe2200039.
PMID: 38319223
Type 2 diabetes mellitus (T2DM) is defined by a common end point: hyperglycemia diagnosed by fasting plasma glucose, plasma glucose during an oral glucose tolerance test, or hemoglobin A1c without...
7.
Blood A, Chang L, Colling C, Stern G, Gabovitch D, Feldman G, et al.
Prim Care Diabetes
. 2024 Feb;
18(2):202-209.
PMID: 38302335
Aim: Describe the rationale for and design of Diabetes Remote Intervention to improVe use of Evidence-based medications (DRIVE), a remote medication management program designed to initiate and titrate guideline-directed medical...
8.
Dichtel L, Corey K, Haines M, Chicote M, Lee H, Kimball A, et al.
J Clin Endocrinol Metab
. 2023 Jun;
108(12):e1542-e1550.
PMID: 37379033
Context: Overweight and obesity are associated with relative growth hormone (GH) deficiency, which has been implicated in the development of nonalcoholic fatty liver disease (NAFLD). NAFLD is a progressive disease...
9.
Colling C, Bredella M, Fazeli P, Pachon-Pena G, Singh R, Rosen C, et al.
Am J Physiol Endocrinol Metab
. 2023 Apr;
324(6):E506-E513.
PMID: 37053050
Chronic caloric deprivation and obesity are complicated by hypercortisolemia. The effects of acute overfeeding and fasting on circulating free cortisol levels and conversion of cortisone to free cortisol are unknown....
10.
Stamou M, Colling C, Dichtel L
Maturitas
. 2022 Nov;
168:13-19.
PMID: 36370489
Normal aging is linked to various endocrine gland changes, including changes in the adrenal glands. Aging is linked to alterations of the hypothalamic-pituitary-adrenal (HPA) axis, including an increase in cortisol...